Get started
Author

Angélica Corral

Observed names: A. Corral, Ang??lica Corral, Angelica Corral, Angélica Corral
ORCID: 0000-0001-5001-4679
Observed ORCID: 0000-0001-5001-4679
OpenAlex ID: A5031835893
Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T Polymorphism at the Multidrug Resistance Gene 1
2005 · S. R. Novoa, P. Barreiro, et al. · Clinical Infectious Diseases · 116
High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients
2007 · Silvina Masciotra, Carolina Garrido, et al. · AIDS · 76
Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests
2009 · Carolina Garrido, Natalia Zahonero, et al. · Journal of Clinical Microbiology · 72
Resistance to Nonnucleoside Reverse-Transcriptase Inhibitors and Prevalence of HIV Type 1 Non-B Subtypes Are Increasing among Persons with Recent Infection in Spain
2005 · C. d. Mendoza, C. Rodriguez, et al. · Clinical Infectious Diseases · 58
PDF
Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors
2007 · E. Poveda, C. de Mendoza, et al. · Journal of Antimicrobial Chemotherapy · 57
Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir
2005 · Julie A Sheldon, Angélica Corral, et al. · AIDS · 53
Preparation and Characterization of Antimicrobial Films Based on LDPE/Ag Nanoparticles with Potential Uses in Food and Health Industries
2018 · Dania Olmos, Gloria Pontes-Quero, et al. · Nanomaterials · 44
PDF
Prevalence of X4 tropic HIV‐1 variants in patients with differences in disease stage and exposure to antiretroviral therapy
2007 · Eva Poveda, Verónica Briz, et al. · Journal of Medical Virology · 44
Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes
2008 · Eva Poveda, Carmen de Mendoza, et al. · AIDS · 41
Changing Rates and Patterns of Drug Resistance Mutations in Antiretroviral-Experienced HIV-Infected Patients
2007 · Carmen De Mendoza, Carolina Garrido, et al. · AIDS Research and Human Retroviruses · 41
High prevalence of natural polymorphisms in Gag (CA-SP1) associated with reduced response to Bevirimat, an HIV-1 maturation inhibitor
2010 · Eduardo Seclén, María del Mar González, et al. · AIDS · 40
Predictors of selection of K65R
2004 · Luisa Valer, Luz Martín-Carbonero, et al. · AIDS · 40
Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors
2007 · E. Poveda, C. Garrido, et al. · Journal of Antimicrobial Chemotherapy · 35
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance
2006 · Carmen de Mendoza, Luisa Valer, et al. · AIDS · 35
Antiretroviral Recommendations May Influence the Rate of Transmission of Drug‐Resistant HIV Type 1
2005 · Carmen de Mendoza, Carmen Rodriguez, et al. · Clinical Infectious Diseases · 34
PDF
Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated Patients
2003 · Oscar Gallego, Carmen de Mendoza, et al. · Journal of Clinical Microbiology · 33
Evidence for Differences in the Sexual Transmission Efficiency of HIV Strains with Distinct Drug Resistance Genotypes
2004 · C. de Mendoza, C. Rodriguez, et al. · Clinical Infectious Diseases · 31
Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid
2002 · Carmen de Mendoza, Jorge del Romero, et al. · AIDS · 31
Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals
2004 · Oscar Gallego, Luz Martin-Carbonero, et al. · Journal of Virological Methods · 26
Short Communication High Risk of Endothelial Dysfunction in HIV Individuals May Result from Deregulation of Circulating Endothelial Cells and Endothelial Progenitor Cells
2011 · Mariola López, Eugenia Vispo, et al. · AIDS Research and Human Retroviruses · 23
Changing Patterns in HIV Reverse Transcriptase Resistance Mutations after Availability of Tenofovir
2008 · Carmen de Mendoza, Inmaculada Jiménez‐Nacher, et al. · Clinical Infectious Diseases · 19
Short Communication: Prevalence of G333D/E in Naive and Pretreated HIV-Infected Patients
2002 · Oscar Gallego, Angélica Corral, et al. · AIDS Research and Human Retroviruses · 19
Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations
2004 · Daniel González de Requena, Oscar Gallego, et al. · AIDS · 18
Fibrous nanocomposites based on EVA40 filled with Cu nanoparticles and their potential antibacterial action
2019 · Jorge Teno, Angélica Corral, et al. · Materials Today Communications · 15
PDF
Changes in Drug Resistance Patterns following the Introduction of HIV Type 1 Non-B Subtypes in Spain
2009 · Carmen De Mendoza, Carolina Garrido, et al. · AIDS Research and Human Retroviruses · 15
Works count: 38
Citation count: 1,122
H-index: 20
I10-index: 29
Year
Topic
Type